Purchase Order 36C26323P1119

Award Date 9/30/23
Potential Completion Date 11/30/23
Potential Value $335K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $470,708 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for the delivery of an Illumina NextSeq 2000 Sequencing System to the VA Boston Healthcare System Research and Development Department. The original solicitation sought offers for this sequencing system or compatible alternatives, noting the need for compatibility with existing...
The Department of Veterans Affairs (VA) awarded a firm fixed price purchase order to Illumina, Inc. for $572,616.60 to provide specialized next-generation sequencing reagents to support the Minneapolis VA Health Care System's Oncology Strategic Initiative. The contract has a base period with four option years, and the reagents will be used on MiniSeq and NextSeq 550 sequencers. Illumina is the sole manufacturer and distributor of the required AmpliSeq Myeloid Panel, AmpliSeq Library PLUS,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA VISN 2) awarded a $335,250 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 2000 Sequencing System. The solicitation sought to sole source this acquisition to support COVID sequencing efforts at the James J. Peters VA Medical Center. The Research department requires this sequencing instrument to conduct analysis of COVID samples. No subcontractors or set aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VA - VHA) awarded a $409,923 purchase order to Illumina, Inc. as the prime contractor for the delivery, training, and installation of Illumina Next Gen sequencing. The place of performance will be in Pittsburgh, Pennsylvania and work is required to be completed between June 12, 2023 and August 14, 2023 under a firm fixed price contract type. Illumina, Inc. will provide next generation DNA...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $338,350 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for the delivery of a NextSeq 2000 Sequencing System to support the Cleveland VA Medical Center Research Service's role in the VA's national sequencing mission project. According to the original special notice solicitation, this sequencing system is required to maintain data...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 (VA - VHA VISN 10) awarded a $48,209 firm fixed price purchase order to Illumina, Inc. to provide a NEXTSEQ 2000 SILVER SUPPORT PLAN. The support plan is for a NEXTSEQ 2000 sequencing system and will be delivered from October 2023 through October 2024 at the prime contractor's place of performance in Cleveland, Ohio. The VA - VHA oversees healthcare services for veterans through regional...
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed price purchase order to Illumina, Inc. for a NextSeq 550DX Sequencing System and associated supplies. This sole-source award was made on September 17, 2019, with a potential value of $342,242.72 and a completion date of September 16, 2020. Illumina is a manufacturer of genomic sequencing and analysis instruments and reagents, and has previously provided similar products and services to federal agencies like...
The Department of Veterans Affairs (VA) awarded a $449,999.98 firm fixed price contract to Illumina, Inc., a manufacturer of DNA sequencing equipment, to provide a specialized Illumina NextSeq 550 DNA Sequencing system. This sole source contract was awarded without a set-aside designation, leveraging Illumina's patented and proprietary technology that the agency determined was the only option to meet their requirements. The contract was awarded to support the VA Boston Healthcare System's...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $38,946 firm fixed price purchase order to Illumina, Inc. to provide MISEQ reagents. The contract has a one-year period of performance beginning October 1, 2023 through September 30, 2024 for delivery to a location in San Diego, California. As the VA-VHA works to deliver healthcare services to veterans, this award will support their genomic sequencing needs through equipment and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 (VA - VHA VISN 6) awarded a $343,449.20 firm fixed price purchase order to Government Scientific Source Inc., doing business as G S S, to deliver a next generation DNA sequencer and related supplies and services. The original solicitation, numbered 36C24624Q0024, sought offers for a benchtop sequencer capable of whole exome sequencing, RNA sequencing, and metabolomics with a run time of less...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 (VA - VHA VISN 23) awarded a $334,594.75 firm fixed price purchase order to Illumina, Inc. to deliver a next generation sequencing system. The sequencing system will support massively parallel sequencing of DNA and RNA samples with throughput of 100-400 million reads per run and targeted resequencing panels in oncology, as requested in Solicitation 6640. The sequencing system, installation, training, and warranty will be provided at the Minneapolis VA Health Care System facility in Minneapolis, Minnesota by November 30, 2023 to support the Agency's biomedical research programs. There is no set-aside designation associated with this award made under the lowest price technically acceptable evaluation method.

Generated 12/29/23, 3:53 PM